Sernova (TSE:SVA) Sets New 1-Year Low at $0.37

Shares of Sernova Corp. (TSE:SVA) reached a new 52-week low during trading on Monday . The company traded as low as C$0.37 and last traded at C$0.37, with a volume of 144113 shares changing hands. The stock had previously closed at C$0.40.

Analyst Ratings Changes

Separately, Raymond James set a C$1.50 price objective on shares of Sernova and gave the company a “market perform” rating in a research note on Thursday, April 4th.

Sernova Stock Down 5.0 %

The company has a market cap of C$115.30 million, a price-to-earnings ratio of -2.92 and a beta of 1.60. The company has a current ratio of 1.20, a quick ratio of 18.11 and a debt-to-equity ratio of 16.55. The business has a fifty day moving average price of C$0.52 and a two-hundred day moving average price of C$0.62.

Sernova (TSE:SVA) last released its quarterly earnings data on Monday, March 18th. The company reported C($0.03) EPS for the quarter, hitting analysts’ consensus estimates of C($0.03). On average, equities analysts predict that Sernova Corp. will post -0.08 earnings per share for the current year.

About Sernova

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.